Log in to search using one of your social media accounts:

 

Sponsored Collection | Accelerating the path from structure to function through integrated structural biology solutions
(Source: ScienceNOW)
Source: ScienceNOW - October 12, 2017 Category: Science Tags: Botany, Cell Biology, Medicine, Diseases, Neuroscience, Pharmacology, Toxicology opms-sups Source Type: news

Metronidazole Injection, USP (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 11, 2017 Category: Drugs & Pharmacology Source Type: news

Dextrose 5% Injection Bags (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 11, 2017 Category: Drugs & Pharmacology Source Type: news

Medical Imaging Drugs Advisory Committee Charter
The Medical Imaging Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2017 Category: Drugs & Pharmacology Source Type: news

Format and Content of a REMS Document Guidance for Industry
Drug Safety (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2017 Category: Drugs & Pharmacology Source Type: news

Nonprescription Drugs Advisory Committee
he Nonprescription Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 10, 2017 Category: Drugs & Pharmacology Source Type: news

Study finds no evidence linking reflux medicines to bone fractures
A new study in Alimentary Pharmacology& Therapeutics reports that proton pump inhibitors (PPIs) are not linked to an increased risk of bone fractures or bone thinning, as it was previously believed.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 10, 2017 Category: Endocrinology Source Type: news

Uloric (Febuxostat) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 10, 2017 Category: Drugs & Pharmacology Source Type: news

Faslodex (Fulvestrant) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 10, 2017 Category: Drugs & Pharmacology Source Type: news

Aspirin vs. NSAIDs (Side Effect and Use Differences)
Title: Aspirin vs. NSAIDs (Side Effect and Use Differences)Category: MedicationsCreated: 10/10/2017 12:00:00 AMLast Editorial Review: 10/10/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 10, 2017 Category: Drugs & Pharmacology Source Type: news

BU researcher receives grant to better understand lymphoblastic leukemia
(Boston University School of Medicine) Hui Feng, M.D., Ph.D., assistant professor of pharmacology and medicine at Boston University School of Medicine (BUSM), is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 10, 2017 Category: Cancer & Oncology Source Type: news

Combination treatment targeting glucose in advanced brain cancer shows promising results in preclinical study
UCLA HealthPositron emission tomography images show glioblastoma tumor glucose uptake before, left, and after treatment in mice.FINDINGSUCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by David Nathanson, a member of UCLA ’s Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor’s nutrients and energy supply. This treatment then stimulates cell death pathways — which control the cancer cells’ fat...
Source: UCLA Newsroom: Health Sciences - October 9, 2017 Category: Universities & Medical Training Source Type: news

Penicillin Misconceptions May Raise Post-Op Infection Risk
Many patients wrongly report a drug allergy, leading doctors to use inferior meds, study finds Source: HealthDay Related MedlinePlus Pages: After Surgery, Drug Reactions (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 9, 2017 Category: Consumer Health News Source Type: news

RPS and APTUK statement of intent for partnership working
Pharmacists and pharmacy technicians: working together for patients The Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians United Kingdom (APTUK) share a number of common (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 9, 2017 Category: Drugs & Pharmacology Source Type: news

Evomela (Melphalan for Injection, for Intravenous Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 9, 2017 Category: Drugs & Pharmacology Source Type: news

Soliqua Injection (Insulin Glargine and Lixisenatide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 9, 2017 Category: Drugs & Pharmacology Source Type: news

Synalgos DC (Aspirin, Caffeine, and Dihydrocodeine Bitartrate Capsules, USP) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 9, 2017 Category: Drugs & Pharmacology Source Type: news

FDAnews Announces — New Book — Clinical Trials Adverse Event Reporting...
The FDA requires clinical trial sponsors to report any patient’s serious adverse drug reaction if the sponsor determines that the “information qualifies for reporting” under section 312.32 of its...(PRWeb October 09, 2017)Read the full story at http://www.prweb.com/releases/FDAnews/ctadverseeventreporting/prweb14756180.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 9, 2017 Category: Pharmaceuticals Source Type: news

Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) approved Zilretta (triamcinolone acetonide extended-release injectable suspension), the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Methylprednisolone Sodium Succinate for Injection, USP (Updated - Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Potassium Phosphate Injection (Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Postmarketing Requirements and Commitments: Reports
Added: Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability (FY2012) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Asacol vs. Humira
Title: Asacol vs. HumiraCategory: MedicationsCreated: 10/6/2017 12:00:00 AMLast Editorial Review: 10/6/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 6, 2017 Category: Drugs & Pharmacology Source Type: news

Lisinopril Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

Furosemide Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

NHS England seeks pharmacy team faces for latest campaign
NHS England is looking for community pharmacy team members to feature in a new national advertising campaign. The aim of the campaign, which is expected to run in 2018, will be to increase use of com (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

Pfizer to FDA: Ban side effect warnings  
Big Pharma won’t be satisfied until every American adult — and even some kids — are taking one of their dangerous statin drugs. And they’ve resorted to desperate measures to achieve that goal. Here’s what’s going on… As you probably know, one of the most common side effects of taking statins is muscle pain. I see this all the time at my clinic when new patients come to see me. And if you or someone you know takes these drugs, you’ve probably seen it, too… But a new study claims that people only get statin side effects like muscle pain if they know they’re taking...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

RPS Wales provides further evidence to Health Committee
The RPS in Wales has called on Welsh Assembly Members to support greater investment in pharmacists to tackle increasing concerns about the use of antipsychotic medication to control the behavioural an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

RPS in Wales provides further evidence to Health Committee on antipsychotic medication
The RPS in Wales has called on Welsh Assembly Members to support greater investment in pharmacists to tackle increasing concerns about the use of antipsychotic medication to control the behavioural an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

Savaysa (Edoxaban Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 5, 2017 Category: Drugs & Pharmacology Source Type: news

RPS talks to ITV's Save Money: Your Health about cold and flu remedies
RPS England Board member Sultan'Sid' Dajani appeared on ITV's Save Money:Your Health in a piece about the price differences between branded and generic medicines. Sid advised people to ta (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 4, 2017 Category: Drugs & Pharmacology Source Type: news

Verzenio (Abemaciclib Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 4, 2017 Category: Drugs & Pharmacology Source Type: news

Fiasp (Insulin Aspart Injection for Subcutaneous or Intravenous Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 4, 2017 Category: Drugs & Pharmacology Source Type: news

Anxiolytics (for Anxiety) Drug Class Side Effects
Title: Anxiolytics (for Anxiety) Drug Class Side EffectsCategory: MedicationsCreated: 10/4/2017 12:00:00 AMLast Editorial Review: 10/4/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 4, 2017 Category: Drugs & Pharmacology Source Type: news

Analysis highlights the importance of pharmacology measures in early clinical trials
(Wiley) A new analysis published in the British Journal of Clinical Pharmacology indicates that 'first-in-man' clinical trial protocols in the Netherlands often lack a consistent consideration of pharmacokinetic and pharmacodynamic aspects in establishing drug doses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2017 Category: International Medicine & Public Health Source Type: news

FDA Approves Botox Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines
DUBLIN, Oct. 3, 2017 /PRNewswire/ -- Today Allergan plc (NYSE: AGN) announced the FDA approval of Botox Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

FDA unveils new search tool for Adverse Event Reporting System
The FDA said this week it launched a new search tool for its adverse event reporting system dashboard to allow users to access reports of adverse drug reactions. FDA Commissioner Dr. Scott Gottlieb said the changes are intended to “better inform patients and health care professionals of adverse events reported with drug and biologic products.” “While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data. For example, while FAERS contains reports on adver...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

November 1, 2017: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

October 31, 2017: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Medical Device Alert: Professional use HIV test: Alere HIV Combo – risk of false positive results
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for Professional use HIV test: Alere HIV Combo manufactured by Alere. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Expanded Access to Investigational Drugs for Treatment Use — Qs & As
Procedural (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Expanded Access to Investigational Drugs for Treatment Use — Qs & As
Procedural (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Cipro vs. Flagyl (Differences between Side Effects and Uses)
Title: Cipro vs. Flagyl (Differences between Side Effects and Uses)Category: MedicationsCreated: 10/3/2017 12:00:00 AMLast Editorial Review: 10/3/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Pharmacy Quality Payments – Guidance for the November 2017 Declaration
NHS England has issued new guidance for community pharmacies wishing to claim payments this year under the Quality Payments Scheme.‘Pharmacy Quality Payments– Guidance for the November 2 (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 2, 2017 Category: Drugs & Pharmacology Source Type: news

Water with lemon will not flush toxins from your body
The drink first thing in the morning is said to  stimulate the liver to flush out waste. But an Australian pharmacologist said detoxing diets or supplements are a marketing scam. (Source: the Mail online | Health)
Source: the Mail online | Health - October 2, 2017 Category: Consumer Health News Source Type: news

Rigel Provides Update on FDA Review of Fostamatinib for ITP
SOUTH SAN FRANCISCO, Calif., Oct. 2, 2017 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that during the company's mid-cycle meeting with the U.S. Food and Drug Administration (FDA) the FDA indicated that, at this point,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 2, 2017 Category: Drugs & Pharmacology Source Type: news

UTSA receives $200,000 grant for cancer drug research
(University of Texas at San Antonio) Doug Frantz, the Max and Minnie Tomerlin Voelcker Distinguished Professor in Chemistry at The University of Texas at San Antoni, has received a $200,000 grant from the Cancer Prevention& Research Institute of Texas to support his research with April Risinger, assistant professor of pharmacology at UT Health San Antonio, to create new cancer drugs from complex natural products that have proven to be enormously effective in fighting the most aggressive types of cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 2, 2017 Category: Biology Source Type: news

Streptococcal  B vaccine during pregnancy cost effective?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2017 Category: Drugs & Pharmacology Source Type: news

Healthcare quality is key in Saudi Arabia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2017 Category: Drugs & Pharmacology Source Type: news